日本消化器外科学会雑誌第39巻第2号
|
|
- ああす えいさか
- 5 years ago
- Views:
Transcription
1
2 Fig. Thenumberofcasesandtheage χ
3 Table Patientscharacteristics (Aged8andover) Non-(A) (Agedintheirs) Non-(B) (Agedintheirs) Numberofcases Meanage(years) Gender;Male/Female Preoperativecomplications Cardiacmorbidity Pulmonarymorbidity Liver/Renaldysfunction Diabetes Malignancy Meannumberofcomplications (.%) 8.8 / 8(9.%). (9.%). /9 (8.%). (8.%).8 9/ 8(.%). Table Thesiteofperforationandprimarydisease Non-(A) Non-(B) Siteofperforation Stomach/Duodenum Smalintestine Appendix Colon/Rectum Galbladder Primarydisease Pepticulcer Appendicitis Cholecystitis Otherbenigndisease (Diverticulitis/Ischemiccolotis/Idiopathic) Malignancy Others(Iatrogenic/Injury/Foreignbody) 8 8
4 Table Laboratorydataonadmissionandpreoperativefactors Non-(A) Non-(B) Laboratorydata WBC(/μl) Hb(g/dl) PLT( /μl) CRP(mg/dl) AST(IU/l) ALT(IU/l) TP(g/dl) Alb(g/dl) BUN(mg/dl) Cr(mg/dl) po(torr) pco(torr) ph Preoperativeshock Timefrom onsettooperation(hr) 8,98+/-,9.+/-..+/-.9.+/-. 8.+/-. 9.+/-9..+/-..+/-..+/-.8.9+/-. 9.+/-8..+/-..+/-. (9.%).+/-.8 9,+ /-,9.+ /-..+ / /-..+ /-..9+ /-9..+ /-..+ /-.8.+ / / /-..+ /-..9+ /-.8 (.%).+ /-. 9,+ /-,8.+ /-.8.+ / / / /-..+ / /-..+ /-..+ / /-..+ / /-. (.%).+ /-.
5 Table Operativeprocedures Non-(A) Non-(B) Stomach/Duodenum Omentalimplantation Gastrectomy (8.%) (.%) (%) (%) (%) SmalIntestine Directsuture Enterectomy (%) (%) (%) (%) Appendix Appendectomy 8 (8.%) (%) (%) Colon/Rectum Colectomy Hartmannoperation (%) 8(8%) (.%) 9(.%) (.%) (.%) Galbladder Cholecystectomy (%) (%) Malignancies Curativeoperation Paliativeoperation () () ( );Two-StageOperation Operationtime(min) Bloodloss(ml) +/ +/ / + / 9+ / 8+ / Table Postoperativecourse Non-(A) Non-(B) Postoperativemanagement Respirator Catecholamines Postoperativemorbidity Majorcomplications Pulmonarymorbidity Cardiacmorbidity Sepsis/DIC/MOF Others Minorcomplications Postoperativehospitalstay(days) 8(8.%) (.%) (8.%) (.%) 8 9(.%).9+/. (.%) (8.%) (8.%) (.%) (.%).+ / 8. 9(.%) (.%) 8(.%) (.%) 8 (.%).+ / 8.
6 Prognosis Alive ADLdecline Dead Operativedeath POD * -<days POD->days Otherdeath Hospitaldeath Table Prognosis Non- Non- (A) (B) (.%) (8.%) (.8%) 8(.8%) (.%) (.%) (.%) Table Prognosiswitheachorgan Stomach / Duodenum (.%) Smalintestine Appendix Colon Rectum Galbladder /8 (.%) / (.%) Non- (A) /9 (%) / (.%) / Non- (B) / (.%) / (.%) / (.%) (9.%) (.%) Total / (.%) 9/ (.%) / (.%)
7 Table8 CharacteristicsandclinicalcourseofsixpatientswithADLdecline Age/ Gender 8/F 8/F 8/F 88/F 8/F 8/F Primarydisease Gastriculcer Gastriculcer Cecalcancer Cholecystitis Duodenalulcer Majorpostoperative complications Respiratoryfailure Pulmonaryedema Respiratoryfailure Respiratoryfailure BrainInfarction (-) Pseudomembranousenterocolitis Rectaldiverticulitis Respiratoryfailure Pneumonia Intra-abdominalabscess Postoperative hospitalstay (days) 9 Postoperative rehabilitation No Remarks Changehospital(tofamilydoctor) Enteralnutrition carenursingfacility Braininfarction (Postoperativecomplication) carenursingfacility carenursingfacility Long-term careinsurance Day-Service
8
「東京都子供・子育て支援総合計画」中間見直し版(案)第2章 子供と家庭をめぐる状況
1 (1) (2) (3) (4) (5) (6) (7) (8) 2 (1) (2) (3) (4) (5) (6) (7) 10,000 100% 8,000 78.7% 78.1% 79.3% 78.3% 74.1% 75.4% 73.2% 80% 6,000 46.6% 47.5% 50.9% 51.5% 49.9% 51.8% 52.2% 60% 4,000 2,000 3,713
More information2NIBS CSK 3 20kg NIBS SLA DRBI(D/DDQA(D/D DQBSO9 S10/S10 Table ,2 E 1 2 1,2,5 2,5 15
食用以外に利用される豚について 齋藤敏樹 ( 日本生物科学研究所 ) Saitoh, T. (2009). Nutlization of a swine other than food ALL about SWINE 35, 14-20 1 2 3 3 12 160 180 kg 12 60 80 kg 12 30 kg NIBS Fig. 1 1995 2007 Table 1 2007 1,300
More information16 10 19
16 10 19 1 1 10 10 11 10 12 10 2 13 10 14 10 15 16 15 17 15 18 15 19 15 20 21 20 22 20 23 20 24 20 3 26 28 29 30 31 32 33 34 35 36 38 39 40 41 42 4 10 10 11 10 12 10 13 10 5 14 10 15 16 15 17 15 18 15
More informationXV-Z10000(J)Ł\1-4.p65
http://www.sharp.co.jp/ 4 2-JW age 2 2..5, :42 2 age 2 2..5, :44 3 age 3 2..5, :44 4 2..5, :44 age 4 5 2..5, :44 age 5 6 2..5, :44 age 6 7 2..5, :44 age 7 8 age 8 2..5, :45 75 76 9 age 9 2..5, :45 4 4
More informationN 847 1085 1932 2966 3336 6302 % 43.8 56.2 100 47.1 52.9 100 28 72 41.34 28 77 51.52 N 84 750 580 478 28 12 1932 % 4.3 38.8 30.0 24.7 1.4 0.6 100 N 1079 2710 1318 1083 60 52 6302 % 17.1 43.0 20.9 17.2
More information, Copyright (c) 2006
1 Copyright (c) 2006 15 9 1570 1,188 858 2006 4 6 17 2006 4 27 28 2 Copyright (c) 2006 3 Copyright (c) 2006 . ( ) WBC) 4 Copyright (c) 2006 Copyright (c) 2006 5 . W W 6 Copyright (c) 2006 Copyright (c)
More information日本消化器外科学会雑誌第40巻第1号
Fig. Classificationofthe9patientsinacuteabdomen Fig.2 DiagnosisandtherapyforthepatientswithoutemergencyCT Fig.3 Diagnosisandtherapyforthepatientswithacuteappendicitisandotherdiseasesnecessitatingdiferentialdi
More information日本消化器外科学会雑誌第23巻第2号
Key words: carcinoma of the pancreatic head, carcinoma of the periampullary region, operative results of the pancreatic duodenal carcinoma, mode of tumor spread of the pancreatic duodenal carcinoma, factors
More information日本化学療法学会雑誌第54巻第1号
Chlamydophila pneumoniae Chlamydophila psittaci Mycoplasma pneumoniae Legionella pneumophila C. pneumoniae C. psittaci C. pneumoniae C. psittaci M. pneumoniae M. pneumoniae C. psittaci L. pneumophila C.
More informationTable 1 Comparsion of background of the 86 patients with colorectal perforation All Survival Death p-value No. of patients 86 (100%) 74 (86%) 12 (14%)
Japanese Journal of Acute Care Surgery 2013; 3: 55~60 原著 非外傷性大腸穿孔 86 症例の臨床的検討 上田健太郎岩﨑安博山添真志川副友川嶋秀治國立晃成酒谷佳世山上裕機加藤正哉 x 所属 : 和歌山県立医科大学救急集中治療医学講座住所 : 641-8510 和歌山県和歌山市紀三井寺 811-1 Table 1 Comparsion of background
More information日本呼吸器学会雑誌第44巻第5号
Table1 Referencesfor(Aex)ofIP researcher term foraex n() age %dead journal Kondoh 3(3) 61.0 Chest1993;103:1808 Akira accelerateddeterioration 17(14) 63.2 52.9 Am JRoentgenol1997;168:79 Stern advancediprequiringmechanical
More information日本化学療法学会雑誌第58巻第2号
Key words β Candida Table1. MCFGCPAstudygroup Investigator (representative) YoshitsuguMiyazaki NaoyukiMiyashita RyoichiAmitani KenjiOgawa AtsuyukiKurashima ToshiroKiguchi MichiakiMishima YuichiInoue HiroshiSaito
More information日本化学療法学会雑誌第54巻第S-1号
β β β Key words β β I HP- -CD CHR RHC R R R R CHR R R R R RHC R R R CHR R R R RHC CHR R H CH CH Fig.. Structuralformulaofhydroxypropyl-β -cyclodextrin(hp-β -CD). CH n H β β β β Table-. Dosageandadministration(Singleadministrationstudy)
More information日本化学療法学会雑誌第56巻第1号
β β β β β Streptococcus pneumoniaehaemophilus influenzaemoraxella catarrhalismycoplasma pneumoniaechlamydia pneumoniae β Key wordsβ mys nilc laci ngis Table. Assessmentschedule Parameters Patientcharacteristics
More information日本化学療法学会雑誌第59巻第5号
Streptococcus pneumoniae Haemophilus influenzae Moraxella catarrhalis S. pneumoniae H. influenzae M. catarrhalis S. pneumoniae H. influenzae M. catarrhalis S. pneumoniae H. influenzae M. catarrhalis S.
More information130318_CJLSG1203_●●高齢者CRFrivese
症例選択基準:4.0. はいいいえ 病理学的に診断され 根治的胸部放射線治療不能である進行または再発非小細胞肺癌患者 初回治療で プラチナ製剤 ( カルボプラチン シスプラチン ) を含む 2 剤または 3 剤併用療法を施行された患者 初回治療開始日の年齢 70 歳以上 2010 年 1 月から 2012 年 6 月末までにプラチナ製剤を含む 2 剤または 3 剤併用療法を開始した患者 1 次治療開始前状況
More information01 Total assist Total assist 02
01 Total assist Total assist 02 03 Total assist Total assist 04 05 Total assist Total assist 06 07 Total assist Total assist 08 09 Total assist Total assist 10 11 Total assist Total assist 12 0120-650-350
More information- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - 1979 54 2010 22 2012 24 2005 17 2007 19 2007 19 18 1992
More information3 JAS JAS JAS 4
1 2 3 JAS JAS JAS 4 5 6 7 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ph 102 106 K 31 32 13 3 15 79 33 34 35 36 37 20 6 H.22.3 http://www.caa.go.jp/foods/pdf/syokuhin19.pdf 38
More information日本化学療法学会雑誌第57巻第6号
Streptococcus pneumoniae Haemophilus influenzae Moraxella catarrhalis S. pneumoniae S. pneumoniae β β H. influenzae S. pneumoniae H. influenzae M. catarrhalis Key words Otalgia Fever Item Crying,Iritation,
More informationKekkaku Vol. 84, No. 10 : 667_673, 要旨 ± % % % % Performance status PS PS % P
Kekkaku Vol., No. : _, 9 要旨.±..% 9.%.%.% Performance status PS PS.% PS INH RFP PZA.% INH RFP.9%.%.%.%.% キーワーズ はじめに ) 対象と方法 Eastern Cooperative Oncology Group Performance status PS ) t- χ % 結果 _ E-mail
More informationCASSIOPEIA E-3000 ユーザーズガイド
Pocket PC 1 3 2 1 u 4 5 6 7 y t 8 r e 9 w q 0 1 2 3 4 5 6 7 8 9 0 q w e r t y u 1 o g i g f d p s a i o p a 1 s d f g 1 1 1 1 1 1 3 2 1 1 1 1 2 1 1 2 1 2 2 2 2 2 2 2 2 (! #$%&
More informationuntitled
Data cleaning Original datan=8479 NCC/ptkgN=7958 NCC10x10E628 8139 NCC/kgPage 1-2) Covariate cleaningcovariate Page Page5-8 Kaplan-Meier method, Log-rank, Cox hazard model Overall survival Cumulative incidence
More information日本消化器外科学会雑誌第41巻第1号
Table Profilesofthepatientswithsevereacutepancreatitis Gender(male:female) Age(years) Etiology Alcohol Cholelithiasis Hyperlipidemia Idiopathic Post-ERCP MHLW severityscore(stage) stage stage stage4 SOFA
More informationP _伊藤.indd
Vol.14, pp.1 13, 2013.3 2 4 40 70 888 : 1980 19871997 1 25.522.6 65 49.247.8 2010 1998 200150 2 3 2007 2000 2000 2010 20102005 2000 2005 2 Vol.14 2006 2 2 Fig.1 4 2010 Fig. 2000 2007 2010 1991 2007 2007
More information200708幸せな結婚を手に入れるレッスン~結婚観~.doc
Counseling Service 1 http://blog.livedoor.jp/cs_hiro/ http://blog.livedoor.jp/cs_fm_moon/ 2007/8/11 2 Counseling Service 3 Counseling Service 4 Counseling Service 5 Counseling Service Counseling Service
More information72 20 Ope / class Alb g/ cm 47.9kg : /min 112/60m
72 20Ope 68 69 2006 4 50 20 / 52 2006 4 1 2006 4 4 24 class 699.4 5 2 5 23 6 6 15 6 19 6 16 Alb2.03+ 7.5g/ 6 21 153.5cm 47.9kg : 36.7 89/min112/60mmHg (-) (-)S1 S2 S3(-) S4(-) - - 6 15 (+) TP4.9g/dl Alb2.0g/
More informationuntitled
-35- -36- -37- -38- 8 7 26 10-39- -40- -41- -42- -43- -44- -45- -46- -47- -48- -49- 20 51 22 23 24 25 26 28 33 34 35 40 41-50- 42 43 44 46 47 48 12 49 11 50 10 51-51- 53 54 55 56 10 57 1983 92 58 10 59
More information日本消化器外科学会雑誌第39巻第10号
WBC Table1 Laboratoryfindings 9,000/μl RBC 396 10 4 /μl Hb 9.8 g/dl adrenaline 46 pg/ml (
More information日本呼吸器学会雑誌第44巻第7号
Table1Laboratoryfindingsonadmission Hematology Serology LungFunctionTest WBC 7,410 /μl CRP 7.7mg/dl VC 3.12L(97.2%) Neut 66.4 % KL-6 777U/ml FEV1.0 2.35L(78.25%) Eosino 3.2 % PT (INR) 0.94 %DLCO 47.6 %
More information10*横山しつよ ほか のコピー
48 2013 Bul. Hijiyama Univ. Jun. Col., No.48, 2013 急性期病院の NST 活動と NST 介入により経過良好をみた症例 脳症を伴う肝硬変, 慢性腎不全患者の閉塞性大腸炎合併 S 字状結腸癌に対し, NSTが協力し治療遂行出来た1 例 Nutrition support team NST NST 60 NST Key words NST Nutrition
More information研修コーナー
l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
More information日本化学療法学会雑誌第60巻第4号
Streptococcus pneumoniae Haemophilus influenzae S. pneumoniae H. influenzae Key words β Streptococcus pneumoniae Haemophilus influenzae S. pneumoniae H. influenzae μ μ S. pneumoniae H. influenzae S. pneumoniae
More information日本化学療法学会雑誌第57巻第S-2号
µ µ Key words µ µ µ I Table1. Subjectprofilesin(A)singleand(B)multiple-dosestudies (A)Single-dosestudy Age (yr) Height (cm) Bodyweight (kg) BMI (kg/m ) Ccr(Cockcroft) (ml/min) Ethnicity dose(mg) n 5 5.1±.,3
More information日本呼吸器学会雑誌第48巻第6号
Fig.1 Cutaneousfindingsandpathologicalfindingsofatransbronchiallungbiopsy(TBLB)andlichenifiedeczemaoftherightforearm.Thepatienthadlichenifiedeczemaonhisextremitiesandbodytrunk (1a:rightforearm,1b:leftthigh).Therewasinfiltrationoftheinflammatorylymphocytes,edemaandabrasioninthetype2alveolarepithelium
More informationNSIPとUCTD(HP用).ppt
NSIP (- NSIP) (Non-) NSIP (Kinder) Retrospective () (Non-) (Kinder) 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 1. 2. RA 3. Scl-70 4. SS-ASS-B 5. Jo-1 6. (>), CRP NSIP 62 6PM/DM* 9 47 *PM/DM: Polymyositis/dermatomyositis
More informationII (No.2) 2 4,.. (1) (cm) (2) (cm) , (
II (No.1) 1 x 1, x 2,..., x µ = 1 V = 1 k=1 x k (x k µ) 2 k=1 σ = V. V = σ 2 = 1 x 2 k µ 2 k=1 1 µ, V σ. (1) 4, 7, 3, 1, 9, 6 (2) 14, 17, 13, 11, 19, 16 (3) 12, 21, 9, 3, 27, 18 (4) 27.2, 29.3, 29.1, 26.0,
More informationTABLE of CONTENTS 11 51 65 187 1 2 3 4 5 6 é é 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
More information日本呼吸器学会雑誌第44巻第1号
β β l β β Table1 Laboratorydataonadmission Hematology WBC 9,910/μl neut 72.4% lym 20.2% eos 0.9% mon 6.1% baso 0.4% RBC 491 10 4 /μl Hb 16.8g/dl Ht 48.3% PLT 29.8 10 4 /μl ESR 3mm/hr Biochemistry TP Alb
More information日本化学療法学会雑誌第59巻第6号
P P Streptococcus pneumoniae S. pneumoniae Key words Streptococcus pneumoniae Fig. 1. Capsular swelling reaction of S. pneumoniae type 6B. Cells are stained dark blue using a methylene blue. Capsule is
More informationVOL.27 CHEMOT S-1 HERAPY 185 に感 性 を示 して い たが,臨 床 的 に は無 効 で あ った 本 症 る 細 菌学 的 に も検 討 した が,起 炎菌 と考 え られ る細 菌 を 例 で は 基礎 疾 患 と して縦 隔 洞腫 瘍 が あ り,既 に 副 腎
CHEMOTHERAPY Table 1 Clinical evaluation of Mezlocillin treatment against respiratory and other infectious diseases *: fever, eruption, granulocytopenia, thrombocytopenia, GOT, GPT elevation (See table
More informationage 3 age 4 2
age 2 1 age 3 age 4 2 age 5 age 6 3 age 7 age 8 4 age 9 age 10 5 0 8 / 0 7 age 11 TARO SUZUKI age 12 6 age 13 age 14 7 HP HP age 15 age 16 8 age 17 age 18 9 age 19 age 20 10 age 21 age 22 11 age 23 age
More information日本化学療法学会雑誌第58巻第4号
Escherichia coli Enterococcus faecalisstreptococcus agalactiae Klebsiella pneumoniae Staphylococcus epidermidis E. colie. faecalispseudomonas aeruginosa K. pneumoniae S. agalactiae E. coli E. coli μ p
More information日本化学療法学会雑誌第54巻第S-1号
β β Key words β Candida krusei Candida glabrata β I β Drugadministration Baselinecharacteristics Clinicalsymptom Mycologicaltests Plasmadrugconcn Adverseevents Laboratorytests ) -leadecg Clinicalphotograph
More information症例報告 2018;25: 当院における小児の溶血性尿毒症症候群に対する腎代替療法期間の検討 福政宏司 *1 谷昌憲 *2 中川聡 *3 要約 : 目的 これまで溶血性尿毒症症候群 (hemolytic uremic syndrome, HUS) の腎機能予後不良因子などは報告されている
症例報告 2018;25:441-6. 当院における小児の溶血性尿毒症症候群に対する腎代替療法期間の検討 福政宏司 *1 谷昌憲 中川聡 要約 : 目的 これまで溶血性尿毒症症候群 (hemolytic uremic syndrome, HUS) の腎機能予後不良因子などは報告されているが, 腎代替療法 (renal replacement therapy, RRT) の施行期間に関する因子の検討はされていない
More information606 Dementia Japan Vol. 29 No. 4 October 2015 Table 1. The day care for people with severe dementia Outline Subjects Personal distribution Medical man
Dementia Japan 29 : 605-614, 2015 605 原著 要旨 1. はじめに 1 26 4.2 80 2 3 A survey of daycare facilities for dementia people in Japan Tohmi Osaki, Kiyoshi Maeda 1 650-0017 7-5 - 2 Medical Center for Dementia,
More informationuntitled
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - - 29 - - 30 -
More informationVOL. 36 S-3 CHEMOTHERAPY 437
VOL. 36 S-3 CHEMOTHERAPY 437 438 CHEMOTHERAPY JULY 1988 Fig. 1 Contractile response of gastrointestinal tract to intravenous administration of saline and EM in interdigestive state in dogs (a) : Saline,
More information日本呼吸器学会雑誌第47巻第6号
Fig.1 A,ChestX-rayfilm demonstratingatumorshadow intherightlowerlungfield.b,chestct scan demonstratingtherightmiddlelobemass,measuring9.0 7.3cm.C,AbdominalCT scanshowingfree airintheabdominalcavityanddirtyfatsignaroundthesigmoidcolontumor.
More informationα β *2 α α β β α = α 1 β = 1 β 2.2 α 0 β *3 2.3 * *2 *3 *4 (µ A ) (µ P ) (µ A > µ P ) 10 (µ A = µ P + 10) 15 (µ A = µ P +
Armitage 1 1.1 2 t *1 α β 1.2 µ x µ 2 2 2 α β 2.1 1 α β α ( ) β *1 t t 1 α β *2 α α β β α = α 1 β = 1 β 2.2 α 0 β 1 0 0 1 1 5 2.5 *3 2.3 *4 3 3.1 1 1 1 *2 *3 *4 (µ A ) (µ P ) (µ A > µ P ) 10 (µ A = µ P
More information日本化学療法学会雑誌第56巻第3号
β Key words Candida albicans albicans Candida C. albicans Candida glabrata Candida krusei albicans Candida C. glabrata C. albicans albicans Candida β in vitro in vivo C. glabrata C. krusei I β γ µ Candida
More information臨床検査値 検査項目名 投与 12 日前 投与日 21 日後 24 日後 26 日後 33 日後 34 日後 35 日後 43 日後 44 日後 45 日後 59 日後 66 日後 TSH(mU/L) FT3(pg/mL
症例の概要 ( 免疫性血小板減少性紫斑病関連症例 ) 1 女悪性黒色腫 70 代 ( 高血圧, 高脂血症, 髄膜腫 ) 2mg/kg 3 週ごとに 2 回 免疫性血小板減少性紫斑病, 甲状腺機能亢進症, 甲状腺機能低下, 多発性脳梗塞 投与 1 年 5 ヶ月前投与 1 年 4 ヶ月前投与 1 年 3 ヶ月前投与 7 ヶ月前投与 2 ヶ月前投与開始日 投与 24 日後 ( 投与日 ) 投与 19 日後投与
More information無印良品 キッチン・テーブル クリーニング・バス用品 2010春夏
200 6 6 7 8 2 4 6 6 7 7 7 2 8 8 9 9 9 20 20 2 22 22 22 24 24 24 25 26 26 28 28 29 29 30 30 3 www.muji.net 32 32 33 34 34 859275 35 39 4 42 35 36 35 37 36 38 39 40 40 40 4 4 42 44 43 45 46 47 47 48 49 50
More information無印良品 キッチン・テーブル・クリーニング・バス用品 2009 春夏
2009 2009 6 6 8 2 4 6 8 8 9 9 9 2 20 20 2 2 2 22 22 22 23 24 25 25 23 26 26 27 27 28 30 30 3 3 32 32 32 www.muji.net 34 34 35 35 35 36 36 37 37 37 38 39 854845 42 43 44 48 38 4 42 42 42 43 43 45 47 46
More information昭歯誌 indd
Dental Medicine Research 32 3 209 213, 2012 209 PET-CT PET-CT PET-CT 2006 8 2009 2 PET-CT 91 46 45 88 2 1 PET-CT 5 5.2 2 1 8 8.2 S 2 1 PET-CT Positron emission tomography-ct PET-CT 18 F-fluorodeoxy glucose
More informationS-6.indd
Structural Health Monitoring with Fiber Optic Deformation Sensor ( SOFO ) SOFO SOFO ( SOFO V ) ( SOFO Dynamic ) 2 SOFO The fiber optic deformation sensor, SOFO, has excellent characteristics such as ease
More informationkenkyuuhoukoku・崎。ィ邏
[ ノート ] 兵庫県における死因別死亡と健康寿命の関連性 沖典男 1 * 長谷美穂 2 Associations between Cause-specific Deaths and Healthy Life Expectancies in Hyogo Prefecture Norio OKI 1 * and Miho HASE 2 1 Infectious Disease Research Division,
More informationデスフルラン
デスフルラン時代の周術期管理 岡山大学麻酔科蘇生科森松博史 デスフルランの特徴!!! 岡山大学での現状 本日のお話 デスフルランの特徴 3 Eger et al. Anesth Analg 1998; 86: 414-21 デスフルランの特徴 2 つのメタアナリシス 2005 Macario et al. Am J Health Syst Pharm!! 2010 Dexter et al.
More informationこんにちは由美子です
Analysis of Variance 2 two sample t test analysis of variance (ANOVA) CO 3 3 1 EFV1 µ 1 µ 2 µ 3 H 0 H 0 : µ 1 = µ 2 = µ 3 H A : Group 1 Group 2.. Group k population mean µ 1 µ µ κ SD σ 1 σ σ κ sample mean
More information_02三浦.indd
36, 7-11, 2016 IPD PCV 5 3 80% 1 invasive pneumococcal disease ; IPD 2010 7 PCV7 2013 13 PCV13 IPD IPD 2,3 2015 1 2015 12 5 1 IPD 2015 1 12 IPD 5 IPD 1 4 2 5 http://pneumocatch.jp/ 5 Statens Serum Institut
More information日本呼吸器学会雑誌第44巻第10号
β Table1 Laboratoryfindingsonthefirstvisit Hematology WBC Neut. Lyn. Mon. Eos. Bas. RBC Hb Ht Plate 5,650 /μl 79.2 % 14.9 % 3.9 % 1.8 % 0.2 % 418 10 4 /μl 12.5g/dl 38.4 % 21.2 10 4 /μl Serology CRP IgG
More informationVOL.39 S-3
VOL.39 S-3 CHEMOTHERAPY SEPT.1991 Table 1. Background of characteristics and allocation of 5 healthy male volunteers in a multiple-dose study on panipenem/betamipron Day 1 Fig. 1. Schedule of multiple-dose
More informationTop 10 causes of death globally 年世界死亡原因トップ 10 Alzheimer disease and other dementias アルツハイマーその他認知症 Trachea, brochus, lung cancers 気管 気管支 肺がん
WHO ファクトシート 死亡原因トップ 10 The top 10 causes of death 2018 年 5 月 24 日 世界の死亡原因トップ 10 2016 年の世界全体で 5690 万人の死亡のうち 半分以上 (54%) はトップ 10 の原因によるものであった とは 2016 年あわせて 1520 万人の死亡を数え 最大の死亡原因である これらの疾病は 過去 15 年の世界の主要死亡原因であり続けている
More informationrectomy as the subjects of study, urinary steroid hormones were measured, and simultaneously the enzyme work and enzyme pattern related to the steroid metabolism, as proposed by Yoshida of our laboratory,
More informationn-jas09.dvi
Vol. 9 (2009 12 ), No. 03-091211 JASCOME CREEP ANALYSIS DISCONTINUOUS ROCK MASS AROUND UNDERGROUND CAVERN 1) 2) 3) Takakuni TATSUMI, Hidenori YOSHIDA and Masumi FUJIWARA 1) ( 761-0396 2217-20, E-mail:
More information日本化学療法学会雑誌第65巻第4号
Mycoplasma pneumoniae M. pneumoniae M. pneumoniae M. pneumoniae M. pneumoniae M. pneumoniae Key words Mycoplasma pneumoniae Mycoplasma pneumoniae M. pneumoniae I M. pneumoniae M. pneumoniae M. pneumoniae
More information日本消化器外科学会雑誌第39巻第1号
χ Table1 linicalfindingsofsignet-ringcelcarcinomainourhospital ge ase (year) Sex Location Stage Morphology ur N H P * Histologicaldepthof invasion,ly,v Survivalafter operation(days) 1 2 4 6 7 4 1 82 24
More information日本化学療法学会雑誌第51巻第2号
piperacillin piperacillin PIPC. g Cmax CL PIPC CL CLR CLNR CL PIPC g g Cmax PIPC Key words: piperacillin Piperacillin PIPC PIPC g g PIPC Cmax g g ml g g ml g g ml T T T PIPC g g T Ccr ml min AUCCmax PIPC
More information48-3 ‰{”R†i74-84†j
Metallic Stents in the Gastrointestinal Tract Shiro Miyayama, M.D., Tetsuya Komatsu, M.D., Keiichi Taki, M.D., Tetsuya Minami, M.D., Chiharu Ito, M.D., Rieko Shinmura, M.D., Shigeyuki Takamatsu, M.D.,
More informationt χ 2 F Q t χ 2 F 1 2 µ, σ 2 N(µ, σ 2 ) f(x µ, σ 2 ) = 1 ( exp (x ) µ)2 2πσ 2 2σ 2 0, N(0, 1) (100 α) z(α) t χ 2 *1 2.1 t (i)x N(µ, σ 2 ) x µ σ N(0, 1
t χ F Q t χ F µ, σ N(µ, σ ) f(x µ, σ ) = ( exp (x ) µ) πσ σ 0, N(0, ) (00 α) z(α) t χ *. t (i)x N(µ, σ ) x µ σ N(0, ) (ii)x,, x N(µ, σ ) x = x+ +x N(µ, σ ) (iii) (i),(ii) z = x µ N(0, ) σ N(0, ) ( 9 97.
More information日本呼吸器学会雑誌第45巻第2号
ADL: Feeding Transfer Dressing Bathing IADL: Shopping Transportation Table1 Spector-KatzIndex * ADL-IADLisevaluatedbythesum ofeachscore(0:totaly dependent,6:totalyindependent) Table2 Generalcharacteristicsofthepatients
More information浜松医科大学紀要
On the Statistical Bias Found in the Horse Racing Data (1) Akio NODA Mathematics Abstract: The purpose of the present paper is to report what type of statistical bias the author has found in the horse
More informationrevise-01.dvi
14???? (2011) 247 3 24 ( ) ( ) (2011 5 20 ; 2011 8 15 ) We examine the value of ΔT at around AD 247. We found that there is a comment in the Jinshu ( ) on the eclipse on March 24, 247 (Julian Calendar).
More information1) Wante AL, Trevino E: Diagnostic features of mucocele of the appendix. Arch Surg 84: 516-524, 1962 2) Aho Aj, Heinonen R, Lauren P: Benign and malignant mucocele of the appendix: His tological types
More information